Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
International journal of laboratory hematology - 43(2021), 2 vom: 15. Apr., Seite e84-e86 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Miller, Connie H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7NL2E3F6K3 |
|---|
| Anmerkungen: |
Date Completed 09.08.2021 Date Revised 09.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ijlh.13384 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317419714 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317419714 | ||
| 003 | DE-627 | ||
| 005 | 20231225163230.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ijlh.13384 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1058.xml |
| 035 | |a (DE-627)NLM317419714 | ||
| 035 | |a (NLM)33174329 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Miller, Connie H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.08.2021 | ||
| 500 | |a Date Revised 09.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Bispecific |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Blood Coagulation Factor Inhibitors |2 NLM | |
| 650 | 7 | |a Isoantibodies |2 NLM | |
| 650 | 7 | |a emicizumab |2 NLM | |
| 650 | 7 | |a 7NL2E3F6K3 |2 NLM | |
| 650 | 7 | |a Factor VIII |2 NLM | |
| 650 | 7 | |a 9001-27-8 |2 NLM | |
| 700 | 1 | |a Boylan, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Payne, Amanda B |e verfasserin |4 aut | |
| 700 | 1 | |a Driggers, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Bean, Christopher J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of laboratory hematology |d 2007 |g 43(2021), 2 vom: 15. Apr., Seite e84-e86 |w (DE-627)NLM167703048 |x 1751-553X |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2021 |g number:2 |g day:15 |g month:04 |g pages:e84-e86 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ijlh.13384 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2021 |e 2 |b 15 |c 04 |h e84-e86 | ||